Human Antibodies & Hybridomas

28-30 October 2015, University of LausanneCHUV, Lausanne, Switzerland

  • Increase font size
  • Default font size
  • Decrease font size

Introduction

Sponsored by the International Journal Human Antibodies
In association with the Integrative Medical Sciences Association

The 19th HUMAN ANTIBODIES & HYBRIDOMAS conference will be held at The University of Lausanne/CHUV, Lausanne, Switzerland.

The HAH 2015 scientific programme will include keynote lectures, contributed papers and poster presentations emphasising all key aspects of human antibody and hybridoma technology, applications and engineering.

Scientific Advisory Committee

Programme Chairman: Professor Mark Glassy (Nascent Biotech, UCSD Moores Cancer Center, San Diego, California, USA)

Mirek Gorny (New York University School of Medicine, New York, USA)
Henry Lowman (CytomX Therapeutics Inc., South San Francisco, California, USA)
Roberto Burioni (Universita Vita-Salute San Raffaele, Milan, Italy)
Jim Larrick (Panorama Research Inc., USA)
Alois Lang (GeNeuro SA, Geneva, Switzerland)
David P. Humphreys (UCB, Slough, UK)
Markus Enzelberger (MorphoSys AG, Martinsried, Germany)
Eszter Nagy (Arsanis GmbH, Vienna, Austria)
Sachdev Sidhu (University of Toronto, Canada)
John Haurum (F-star, Cambridge, UK)
Paul Kerr (Fusion Antibodies, Northern Ireland, UK)
Yan Wu (Kadmon Pharmaceuticals LLC, New York, USA)
Bob Kelley (Genentech Inc., South San Francisco, USA)
David Naor (The Hebrew University, Jerusalem, Israel)
Lynn MacDonald (Regeneron Pharmaceuticals, Tarrytown, New York, USA)
Jody Berry (Proteos Inc., Kalamazoo, Michigan, USA)
Manuel Baca (MedImmune Inc., Gaithersburg, Maryland, USA)
Dale Ludwig (ImClone Inc., New York, USA)
Hermann Katinger (Polymun Scientific Immunbiologische Forschung GmbH, Vienna, Austria)
Dietmar Katinger (Polymun Scientific Immunbiologische Forschung GmbH, Vienna, Austria)
Aaron K. Sato (Sutro Biopharma,Inc., South San Francisco, California, USA)
Andrew T. Serafini (Kilpatrick Townsend Stockton LLP, Seattle, Washington, USA)

Conference Scope

The scope of the HAH 2015 conference falls broadly into nine main session categories:

  • Infectious Diseases
  • Autoimmunity
  • Molecular Biology
  • Emerging Technologies
  • Clinical Applications
  • Therapeutic Antibodies
  • Cancer
  • Anti-Infective Antibodies
  • Intellectual Property & Legal Issues
 

HAH 2015 Delegates

Login details will be supplied after you have registered for the event.


HAH 2015 Sponsors

  • Fusion Antibodies
  • Amplycell
  • Catalent
  • ModiQuest Research
  • Merck Serono & Merck
  • Genedata
  • CytomX Therapeutics
  • F-star
  • Kadmon
  • Boehringer Ingelheim
  • InCellart
  • Mapp Biopharmaceutical
  • ImmunoGen
  • Morphosys
  • Adimab
  • Sutro Biopharma
  • Polimun Scientific
  • UCB
  • Geneuro
  • Kilpatrick Townsend
  • OMT
  • Arsanis Biosciences
  • hVIVO
  • Nascent Biologics
  • Symphogen
  • MacroGenics
  • MAB Discovery
  • NBE Therapeutics
  • Proteos
  • Regeneron
  • Aldevron
  • ImClone Systems

HAH 2015 Downloads

HAH 2015 Leaflet

HAH 2015 Mailing List

Name
E-mail Address
What is 3+2-1?